The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2024 | Reflecting on BTOG 2024: networking and multidisciplinary collaboration
Sanjay Popat, BSc, MBBS, FRCP, PhD, The Royal Marsden NHS Foundation Trust, London, UK, reflects on the enriching experience of the BTOG 2024 annual meeting in Belfast emphasizing the value of networking and multidisciplinary collaboration. With over 200 abstracts submitted, the poster session showcased diverse research expertise, particularly from junior investigators. Prof. Popat highlights the quality of oral presentations, which delved into various aspects of multidisciplinary care, including diagnostics, optimal therapies, and controversies in operable lung cancer management. Of particular interest is the ongoing implementation of ctDNA or liquid biopsies, which shows promising impact on patient care and is anticipated to become a national service in the future. This interview took place at the BTOG 2024 congress in Belfast, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
